Probiotics in Vaginal Microbial Balance
Twelve to 50% of women worldwide experience vaginal microbiome challenges that significantly impact their quality of life. In several clinical studies, daily intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 were shown to promote the health of the vaginal microbiota. In another study, women with vaginal microbiome challenges were randomized to receive placebo or Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. After 6 weeks, significantly more women in the probiotic group maintained a balanced vaginal microbiota compared to women in the placebo group.
A study of post-menopausal women with vaginal microbiome challenges were randomized to receive a placebo or Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. After four weeks, the women who received the probiotic blend maintained a healthy vaginal microbiota within the normal, beneficial range, whereas the balance of vaginal bacteria of the women in the placebo group was not significantly improved.
Probiotics and Urogenital Health
Urinary tract microbiome challenges are very common, impacting 150 million people each year. The specific blend of probiotics in FemFlor has been associated with supporting vaginal and urinary tract health. Specifically, studies suggest these probiotics promote vaginal and urinary tract health when used alone or in combination with common interventions. In other studies, participants consuming this specific probiotic blend maintained a healthy urinary tract microbiota with fewer incidence of urinary tract challenges.
Amount per serving
Proprietary Blend 50 mg (2 Billion CFU++)
Lactobacillus reuteri (RC-14®)
Lactobacillus rhamnosus (GR-1®)
